Smitha Yerrum

Smitha Yerrum

Harvard University

H-index: 10

North America-United States

About Smitha Yerrum

Smitha Yerrum, With an exceptional h-index of 10 and a recent h-index of 9 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cancer Research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Measuring single-cell density with high throughput enables dynamic profiling of immune cell and drug response from patient samples

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system

TMOD-34. PATIENT-DERIVED XENOGRAFT AND CELL LINE MODELS FACILITATE NOVEL TREATMENT DISCOVERY IN CENTRAL NERVOUS SYSTEM LYMPHOMAS

TMOD-03. PAN-CANCER ANALYSIS OF ORTHOTOPIC PATIENT DERIVED XENOGRAFTS FROM BRAIN METASTASES

46. PAN-CANCER ANALYSIS OF ORTHOTOPIC PATIENT DERIVED XENOGRAFTS FROM BRAIN METASTASES

Smitha Yerrum Information

University

Position

Dana Farber Cancer Institute

Citations(all)

749

Citations(since 2020)

297

Cited By

574

hIndex(all)

10

hIndex(since 2020)

9

i10Index(all)

10

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Smitha Yerrum Skills & Research Interests

Cancer Research

Top articles of Smitha Yerrum

Measuring single-cell density with high throughput enables dynamic profiling of immune cell and drug response from patient samples

bioRxiv

2024

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system

JCI insight

2022/10/10

TMOD-34. PATIENT-DERIVED XENOGRAFT AND CELL LINE MODELS FACILITATE NOVEL TREATMENT DISCOVERY IN CENTRAL NERVOUS SYSTEM LYMPHOMAS

Neuro-Oncology

2020/11

TMOD-03. PAN-CANCER ANALYSIS OF ORTHOTOPIC PATIENT DERIVED XENOGRAFTS FROM BRAIN METASTASES

Neuro-Oncology

2020/11

46. PAN-CANCER ANALYSIS OF ORTHOTOPIC PATIENT DERIVED XENOGRAFTS FROM BRAIN METASTASES

Neuro-Oncology Advances

2020/8

See List of Professors in Smitha Yerrum University(Harvard University)